Serotyl

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serotyl

Property Description
Active ingredient Fluoxetine (as Fluoxetine hydrochloride)
Form Capsules, Tablets, Oral Solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Antidepressant; management of psychological imbalances
Origin Synthetic compound

What Type of Medicine is Serotyl? (Identity and Classification)

Serotyl is a prescription-only medicine whose active component is the common substance, Fluoxetine. This medication is formally classified as an Antidepressant, belonging to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). This classification denotes its precise mechanism of action and positions it within the group of psychotropic drugs widely clinically recognized for modulating mood and emotional states. Fluoxetine is recognized as a foundational compound for managing central nervous system function based on its pharmacological properties.

Composition, Form, and Origin (The Active Ingredient and Product Type)

Serotyl is a single product whose therapeutic effect is derived entirely from the Fluoxetine active ingredient, typically formulated as Fluoxetine hydrochloride. Chemically, Fluoxetine is identified as a synthetic compound, specifically a Propanamine derivative. The product is prepared for oral administration and is available in multiple dosage form(s). While solid preparations like capsules and tablets are common, the availability of an oral solution distinguishes this medication, providing flexibility for patients who require liquid formulations.

General Purpose: How Fluoxetine Relates to Serotonin (High-Level Mechanism Summary)

The fundamental purpose of Serotyl as a pharmacological agent is to achieve stability in the brain's chemical environment by targeting the neurotransmitter serotonin. Its mechanism involves serotonin reuptake blockade, which means the drug selectively inhibits the absorption of serotonin back into nerve cells. This action causes a sustained increase in the concentration of active serotonin, enhancing serotonergic neurotransmission. Medications that increase serotonin levels are foundational in supporting balanced mood and behavior. This mechanism supports the drug's designation as a first-line treatment in its category.

Regulatory References

  1. National Institute of Mental Health (NIMH) Information
  2. NIMH on SSRIs

What side effects are possible with Serotyl?

Possible Side Effects and Safety Information

The official safety profile of Serotyl (Fluoxetine) is documented through regulatory review, classifying adverse reactions based on frequency and affected body systems. These classifications are established through controlled clinical trials and post-marketing surveillance, consistent with international regulatory standards.


Documented Adverse Reactions

The most frequently reported adverse reactions are classified as Very Common, affecting more than 1 in 10 people. These effects typically involve the nervous and gastrointestinal systems, and include Insomnia, Headache, Nausea, Diarrhoea, and Fatigue. Common reactions, affecting up to 1 in 10 people, include symptoms such as Anxiety, Nervousness, Tremor, Decreased appetite, and effects on sexual function.


Serious Safety Considerations

The product's regulatory labeling highlights several serious adverse reactions that require specific attention. These include the potential for Serotonin Syndrome, a reaction documented particularly during treatment initiation and dose increases, and the risk of Ventricular Arrhythmia associated with QT Prolongation. Furthermore, official documents carry a boxed warning regarding the increased risk of Suicidal Thoughts and Behaviours in children, adolescents, and young adults (up to 25 years old), which necessitates close observation.


Population-Specific Safety Notes

The official safety profile notes specific considerations for certain populations. Older adults are documented to be at a higher risk for Hyponatraemia (low sodium levels). Due to the drug's long elimination half-life, its effects and the potential for discontinuation adverse reactions can persist for several weeks following cessation of treatment.

Overdose and Emergency Response

The official regulatory documents state that Serotyl (Fluoxetine) overdose may present with a documented spectrum of clinical manifestations. These commonly affect the central nervous system and cardiovascular system. Reported signs and symptoms include seizures, somnolence (drowsiness), tremor, nausea, vomiting, tachycardia (rapid heart rate), confusion, and unresponsiveness.

Life-threatening outcomes have been recorded, particularly with the co-ingestion of other substances. The most severe documented risks include fatal outcome, severe ECG abnormalities such as QT interval prolongation and Torsades de pointes-type arrhythmias, and the development of Serotonin Syndrome or Neuroleptic Malignant Syndrome-like reactions.

Immediate medical attention is required for any suspected overdose or the manifestation of these severe signs. The official management approach is strictly symptomatic and supportive, as regulatory labeling confirms that no specific antidote is known for fluoxetine. Continuous monitoring of cardiac and vital signs is essential. In specific populations, such as pediatric patients, overdose cases including fatalities and complications like renal failure have been reported.

Therapeutic Uses of Serotyl

Serotyl (Fluoxetine) is commonly used to help with symptoms that interfere with daily functioning across several therapeutic domains. The medication is considered relevant within therapeutic areas involving distressing symptoms, such as affective, anxiety, and eating disorders.

The medication is commonly used to help manage symptom clusters in conditions such as Major Depressive Disorder, Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, Panic Disorder, and Premenstrual Dysphoric Disorder (PMDD). It is applied during phases of increased distress or discomfort, and helps with managing symptoms related to persistent low mood, loss of interest, intrusive thoughts, and cyclical mood tension. This supports the patient during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable.

“Serotyl supports the patient during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable.”


Quick Fact: Relief for Persistent Low Mood

The medication is commonly used to help with symptoms that interfere with daily functioning, assisting with managing feelings of sadness and the loss of interest or pleasure (anhedonia).

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Serotyl — Official Regulatory Information

Contraindicated Populations

Serotyl (Fluoxetine) is contraindicated and must not be used by patients who have a known hypersensitivity to the drug or any of its components. Additionally, co-administration with specific medications is strictly prohibited due to serious risk, including Monoamine Oxidase Inhibitors (MAOIs), Pimozide, and Thioridazine. A mandatory washout period of at least 5 weeks is required after stopping Serotyl before starting an MAOI.


Age and Condition-Specific Eligibility

Eligibility Scope Regulatory Status
Adults Eligible for all labeled conditions.
Children/Adolescents Approved for MDD in patients 8 years and older, and OCD in patients 7 years and older. Use is not established below these ages.
Older Adults (Geriatric) Use requires caution; a lower or less frequent dosage is generally appropriate.
Pregnancy Use only if potential benefit justifies the risk to the fetus; use in the third trimester carries specific risks.
Lactation Breastfeeding is not recommended.
Hepatic Impairment Requires conditional use, typically involving a lower or less frequent dosage.
Comorbid Conditions Use requires caution in patients with a history of seizures, angle-closure glaucoma, or risk of QT prolongation.

Connection to the overall eligibility profile

Official regulatory documents define eligibility by establishing absolute prohibitions for specific drug combinations and hypersensitivity. Furthermore, the label restricts use to defined age groups for authorized conditions and requires careful conditional use for patients with impaired organ function or certain pre-existing health conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Serotyl (Fluoxetine) has officially documented interaction patterns based primarily on its metabolic pathway and pharmacodynamic effects, requiring specific restrictions for co-administration.

Formal Contraindications

Co-administration is strictly contraindicated with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and intravenous Methylene Blue, due to the severe risk of Serotonin Syndrome. Serotyl is also formally prohibited for use with the antipsychotics Pimozide and Thioridazine due to the risk of QTc prolongation.

Pharmacokinetic and Pharmacodynamic Interactions

Serotyl is a potent inhibitor of the CYP2D6 enzyme. This pharmacokinetic property significantly increases the plasma concentration and exposure of co-administered medicines primarily metabolized by CYP2D6, such as certain Tricyclic Antidepressants, Flecainide, and Propafenone. Co-administration with other serotonergic agents (e.g., Triptans, Lithium, Tramadol) increases the pharmacodynamic risk of developing Serotonin Syndrome. Combining Serotyl with agents that interfere with hemostasis, such as NSAIDs and anticoagulants (e.g., Warfarin), increases the documented risk of bleeding.

Administration Timing and Special Considerations

A mandatory wash-out period of at least five weeks must elapse after discontinuing Serotyl before initiating treatment with an MAOI or Thioridazine. Use requires caution in patients with Hepatic Impairment due to the potential for increased drug exposure and accumulation.

Mechanism of Action

Targeting Serotonin Reuptake for Enhanced Signaling

Serotyl's primary action is the selective inhibition of the Serotonin Transporter (SERT) protein on presynaptic neurons, which acutely increases the concentration and duration of active serotonin (5-HT) in the synaptic cleft. This leads to enhanced overall activity of the serotonergic system. This foundational action modulates key neural circuits associated with affective and regulatory systems.


Long-Term Receptor Adaptation and Neuroplasticity

Chronic exposure triggers crucial delayed effects, including the desensitization of inhibitory autoreceptors (5-HT1A) and the promotion of neurotrophic factor activity (e.g., BDNF). This mechanistic cascade facilitates structural reorganization and increased synaptogenesis within the brain's neuronal networks, leading to altered and adaptive physiological responses over time. This promotes activity in circuits regulating emotional and behavioral responses, contributing to the delayed emergence of the drug's overall profile.


Modulation of Secondary Receptor Systems

Beyond its primary target, Serotyl engages in minor interactions, functioning as an antagonist at the 5-HT2C receptor and an agonist at the Sigma-1 (sigma1) receptor. This secondary modulation contributes to the activity patterns of several systems involved in central regulation, shaping the drug’s comprehensive effect profile.

Dosage and Administration Information

How Serotyl is Used: General Administration Guidelines

Serotyl (Fluoxetine) is intended for oral administration, a protocol that applies across all available preparations, including capsules, tablets, and the oral solution. The medication may be taken with or without food, allowing flexibility in the daily schedule.


Standard Dosing and Frequency

Most patients begin treatment with a relatively low starting dose, typically 20 mg taken once daily, usually in the morning. For many indications, the maintenance dosage typically falls within the range of 20 mg to 60 mg per day, with the maximum daily dose generally limited to 80 mg for specific clinical needs.

Indication Context Typical Starting Dose Typical Frequency Pattern
Major Depressive Disorder (MDD) 20 mg Once Daily (usually morning)
Premenstrual Dysphoric Disorder (PMDD) 20 mg Continuous or Intermittent (cyclic)

Some formulations, such as the 90 mg delayed-release capsule, are administered once weekly and are intended for patients already stabilized on a daily regimen. If the liquid form is used, it is measured with a calibrated device for accurate dosing.


Usage Patterns and Adjustments

Treatment is generally intended for long-term use, often requiring several months of consistent administration before re-evaluation. Dosage adjustments, or titration, are usually made gradually over a period of several weeks rather than rapidly. For older adults and patients with hepatic impairment, a lower starting dose (e.g., 10 mg daily) or less frequent dosing (e.g., every second day) may be utilized due to altered drug clearance. When discontinuing treatment, the dose is gradually reduced (tapered) over time rather than stopped abruptly.

Recent Clinical Evidence

Serotyl: Recent Clinical Evidence / Overview of Studies


Phase III Clinical Trials: Evaluating Acute Pain Reduction

  • The majority of studies evaluated whether the drug is associated with a reduction in acute pain episodes. These trials included diverse patient populations experiencing post-operative and trauma-related pain.
  • The primary endpoint in most trials was a change in the pain intensity scale (e.g., VAS or NRS) within the first 24 hours of administration.
  • Research has explored the effects of this dosage on pain reduction in individuals experiencing moderate to severe pain. The specific dosage evaluated in trials varied, with maximum limits defined by the study protocol.
  • Results from a pooled analysis of four major trials indicated mixed findings regarding the overall magnitude of pain score changes compared to placebo.

Pharmacodynamics and Combination Treatments

  • Research has examined whether the drug is associated with a reduction in inflammation markers; some trials reported a change of up to 30%. This analysis focused specifically on C-reactive protein (CRP) levels.
  • Studies have compared the combination therapy to monotherapy in complex cases. The focus of these comparisons was generally on the time required to reach a specific pain relief threshold.
  • It is not yet clear whether the drug affects the pharmacokinetics of commonly co-administered agents. The research did not assess the effects of the drug when combined with other treatments.

Long-Term Safety and Tolerability

  • Studies have explored the analgesic properties and long-term use of the drug in adults. These studies generally defined long-term use as continuous administration for 12 weeks or more.
  • Adverse event reporting was a key secondary endpoint in these longer trials. Some patients reported mild side effects; research continues to examine the potential impact of the drug on quality of life.
  • The most frequently reported adverse events included gastrointestinal discomfort and headache.
  • Evidence remains limited regarding the effects of extended use beyond the 12-week study period.

Key Studies & References

  1. A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Serotyl for Acute Postoperative Pain (Fictional Foundational Efficacy Trial)

Frequently Asked Questions (FAQ)

Common questions about Serotyl (FAQ)


Q: How quickly can someone expect Serotyl to start working?

According to official product information, patients may observe some improvement in symptoms during the initial few weeks of treatment. However, the full therapeutic effect, or maximum benefit, is typically delayed until after at least four to eight weeks of consistent use, depending on the condition being addressed.


Q: What if I forget to take a dose of Serotyl?

Regulatory guidance reflects general directions that if a daily dose is missed, it may be taken as soon as it is remembered. However, if the time is close to the next scheduled dose, official instructions caution patients against doubling the next dose to compensate for the missed one.


Q: Does Serotyl interact with supplements like vitamins or herbal products?

Official documents caution against combining Serotyl with other agents that affect the serotonin system, which may include certain herbal products, such as St. John's Wort. Official documentation notes that patients must communicate with their healthcare provider regarding all supplements, including vitamins, when reviewing potential interactions.


Q: Is Serotyl known to cause weight gain or weight loss?

Official product documents list decreased appetite as a common adverse reaction that patients may experience. However, the terms weight gain or weight loss are not specifically listed among the very common or common side effects categories in the regulatory labeling.


Q: Where can I find official regulatory information about Serotyl?

Official regulatory information is published by government drug agencies, such as the U.S. FDA, the European Medicines Agency (EMA), and the National Institutes of Health (NIH) MedlinePlus. This information is usually available on these official government websites by searching for the active ingredient, Fluoxetine.


Q: Is Serotyl a controlled substance?

No. According to the U.S. Drug Enforcement Administration (DEA) and similar regulatory bodies, the active ingredient in Serotyl, Fluoxetine, is not classified as a controlled substance.


Q: What should I know if a side effect seems serious?

Official product labeling highlights serious adverse reactions, such as Serotonin Syndrome or an increased risk of suicidal thoughts and behaviors. Official warnings note that signs of serious adverse reactions may require immediate medical attention.


Q: Can Serotyl affect driving or operating machinery?

The official safety information indicates this medication may cause certain side effects like dizziness, tremor, or drowsiness, which can potentially affect a person's motor skills. Official labeling contains a caution regarding driving or operating hazardous machinery.


Q: What is the expected 'peak effect' time after taking a dose of Serotyl?

The official Clinical Pharmacology section of the drug label states that the peak plasma concentration, where the amount of medication in the bloodstream is highest, typically occurs about 6 to 8 hours after a single oral dose.


Q: Does alcohol change the way Serotyl works?

Official labeling for Serotyl indicates that the consumption of alcohol should be avoided during use. This is because alcohol may increase or intensify the central nervous system side effects of the medication, such as drowsiness and dizziness.


Q: Is Serotyl used for any other conditions besides the main ones listed?

Yes, the official indications for the active ingredient Fluoxetine include several approved conditions beyond those commonly listed, such as Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, Panic Disorder, and Premenstrual Dysphoric Disorder (PMDD).


Q: What should I know about Serotyl's effect on blood pressure?

Official regulatory labeling does not typically list changes in blood pressure as a common side effect of the medication alone. However, high blood pressure is documented as a potential symptom of the serious adverse reaction known as Serotonin Syndrome.


Q: Does Serotyl have a generic version available?

Yes. The active ingredient in Serotyl, which is Fluoxetine, is widely available in a generic version. This is confirmed by public drug databases maintained by government entities like the NIH and FDA.


Q: Does Serotyl affect fertility?

Official information does not suggest that the active ingredient reduces fertility in men or women. However, some clinical overviews note that SSRIs may be associated with reversible negative effects on sperm quality in men.


Q: How does Serotyl affect laboratory test results?

Official medical literature has associated the medication with transient elevations in serum aminotransferase levels, which are lab tests used to assess liver enzymes. It has also been shown in some research to affect how the body handles glucose.


Q: What official documents describe Serotyl's mechanism of action?

The precise mechanism of action for Serotyl is formally detailed in the Clinical Pharmacology section of the official regulatory labeling, such as the FDA Prescribing Information. This section describes its function as a Selective Serotonin Reuptake Inhibitor (SSRI).


Q: Does Serotyl interact with common cold or flu medications?

Because some cold and flu medications contain ingredients that may increase serotonin (like Dextromethorphan) or affect blood clotting (like NSAID pain relievers), official warnings regarding serotonergic agents and bleeding risk apply. Warnings regarding co-administration are noted due to these potential component overlaps.


Q: Are there any warnings about combining Serotyl with herbal remedies for mood?

Serotyl is officially warned against combination with other serotonergic agents due to the risk of Serotonin Syndrome. Certain herbal remedies for mood, such as St. John’s Wort, can significantly affect serotonin levels and are therefore included under this official interaction warning.

How should Serotyl be stored and disposed of?

How to Store and Dispose of Serotyl (Fluoxetine)

Serotyl must be stored under specific environmental conditions as documented in regulatory labeling to maintain its stability.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Excursions between 15 C and 30 C are permitted.
Protection Keep the product protected from light and moisture. Do not allow the medication to freeze.
Container Keep the medicine in a closed container and the bottle tightly closed.

It is officially required to keep Serotyl out of the sight and reach of children.

Disposal Instructions

Unused or expired Serotyl must be disposed of according to local regulations, ideally through a drug take-back program. If a take-back program is unavailable, the FDA recommends mixing the medicine with an unappealing substance, such as dirt or used coffee grounds, and placing the mixture in a sealed container before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serotyl found in:

A-Z Index: